Cecilia Jones - 26 Sep 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Financial Officer
Signature
/s/ William Cook, as attorney-in-fact for Cecilia Jones
Issuer symbol
AGIO
Transactions as of
26 Sep 2022
Net transactions value
$0
Form type
4
Filing time
28 Sep 2022, 16:10:56 UTC
Previous filing
03 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Stock options (right to buy) Award $0 +118,390 $0.000000 118,390 26 Sep 2022 Common stock 118,390 $27.88 Direct F1
transaction AGIO Restricted stock units Award $0 +22,417 $0.000000 22,417 26 Sep 2022 Common stock 22,417 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on September 26, 2022. The shares underlying this option vest as to 25% of the underlying shares on September 26, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.